全文获取类型
收费全文 | 2583篇 |
免费 | 228篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 71篇 |
妇产科学 | 58篇 |
基础医学 | 404篇 |
口腔科学 | 29篇 |
临床医学 | 337篇 |
内科学 | 400篇 |
皮肤病学 | 19篇 |
神经病学 | 290篇 |
特种医学 | 169篇 |
外科学 | 400篇 |
综合类 | 138篇 |
一般理论 | 1篇 |
预防医学 | 228篇 |
眼科学 | 18篇 |
药学 | 163篇 |
肿瘤学 | 92篇 |
出版年
2021年 | 27篇 |
2020年 | 27篇 |
2019年 | 41篇 |
2018年 | 34篇 |
2017年 | 26篇 |
2016年 | 29篇 |
2015年 | 28篇 |
2014年 | 43篇 |
2013年 | 76篇 |
2012年 | 115篇 |
2011年 | 100篇 |
2010年 | 97篇 |
2009年 | 84篇 |
2008年 | 126篇 |
2007年 | 119篇 |
2006年 | 123篇 |
2005年 | 114篇 |
2004年 | 116篇 |
2003年 | 100篇 |
2002年 | 93篇 |
2001年 | 67篇 |
2000年 | 70篇 |
1999年 | 48篇 |
1998年 | 39篇 |
1997年 | 33篇 |
1996年 | 41篇 |
1995年 | 41篇 |
1994年 | 27篇 |
1993年 | 31篇 |
1992年 | 55篇 |
1991年 | 32篇 |
1990年 | 53篇 |
1989年 | 65篇 |
1988年 | 51篇 |
1987年 | 43篇 |
1986年 | 65篇 |
1985年 | 62篇 |
1984年 | 48篇 |
1983年 | 36篇 |
1982年 | 18篇 |
1981年 | 19篇 |
1980年 | 21篇 |
1979年 | 42篇 |
1978年 | 20篇 |
1977年 | 22篇 |
1976年 | 28篇 |
1975年 | 25篇 |
1974年 | 22篇 |
1973年 | 21篇 |
1968年 | 19篇 |
排序方式: 共有2820条查询结果,搜索用时 15 毫秒
1.
OBJECTIVE: This study was designed to investigate potential areas of practice for the clinical laboratory scientist (CLS) and to propose a graduate curriculum to prepare the practitioner for an advanced level of practice. DESIGN: Meta-analysis of PharmD, physician assistant, physical therapy, and nurse practitioner curricula focusing on academic and clinical advanced practice was used to develop an educational model and curriculum for a professional doctorate in clinical laboratory science (CLS). MAIN OUTCOME MEASURE: (1) New educational model for CLS advanced practice; (2) A proposed curriculum for a Doctorate of Clinical Laboratory Science degree. RESULTS: A new curriculum model was adapted from established healthcare educational models. CONCLUSION: Although there is a need for a baccalaureate degree in CLS there is also a role for expanded education and responsibilities for CLS practitioners. The CLS Advanced Practitioner design focuses on moving students from the baccalaureate level to the doctoral level and prepares the individual to become an integral part of the healthcare team. 相似文献
2.
3.
Monica Conciatori Christopher J Stodgell Susan L Hyman Melanie O'Bara Roberto Militerni Carmela Bravaccio Simona Trillo Francesco Montecchi Cindy Schneider Raun Melmed Maurizio Elia Lori Crawford Sarah J Spence Lucianna Muscarella Vito Guarnieri Leonardo D'Agruma Alessandro Quattrone Leopoldo Zelante Daniel Rabinowitz Tiziana Pascucci Stefano Puglisi-Allegra Karl-Ludvig Reichelt Patricia M Rodier Antonio M Persico 《Neuropsychopharmacology》2004,55(4):413-419
BACKGROUND: The HOXA1 gene plays a major role in brainstem and cranial morphogenesis. The G allele of the HOXA1 A218G polymorphism has been previously found associated with autism. METHODS: We performed case-control and family-based association analyses, contrasting 127 autistic patients with 174 ethnically matched controls, and assessing for allelic transmission disequilibrium in 189 complete trios. RESULTS: A, and not G, alleles were associated with autism using both case-control (chi(2) = 8.96 and 5.71, 1 df, p <.005 and <.025 for genotypes and alleles, respectively), and family-based (transmission/disequilibrium test chi(2) = 8.80, 1 df, p <.005) association analyses. The head circumference of 31 patients carrying one or two copies of the G allele displayed significantly larger median values (95.0th vs. 82.5th percentile, p <.05) and dramatically reduced interindividual variability (p <.0001), compared with 166 patients carrying the A/A genotype. CONCLUSIONS: The HOXA1 A218G polymorphism explains approximately 5% of the variance in the head circumference of autistic patients and represents to our knowledge the first known gene variant providing sizable contributions to cranial morphology. The disease specificity of this finding is currently being investigated. Nonreplications in genetic linkage/association studies could partly stem from the dyshomogeneous distribution of an endophenotype morphologically defined by cranial circumference. 相似文献
4.
ALBERTO Q FARIAS LUCIANA L GONÇALVES EDUARDO LR CANÇADO ANTONIO C SEGURO SILVIA B CAMPOS CLARICE P ABRANTES-LEMOS FLAIR J CARRILHO 《Journal of gastroenterology and hepatology》2006,20(1):147-152
Background and Aims: Primary biliary cirrhosis (PBC) might be complicated by osteoporosis, whose etiology remains unknown but seems to be multifactorial. Prevalence rates of 30% to 60% for distal renal tubular acidosis (DRTA) have been reported in PBC patients, generally as incomplete DRTA. Although it is undisputed that a reduced bone mineral density (BMD) is the expected outcome among patients who have been suffering from longstanding chronic metabolic acidosis, it is unclear if incomplete DRTA is also associated with metabolic bone disease in PBC patients. The present study was undertaken to compare the BMD of PBC patients with and without DRTA.
Methods: The BMD of 23 PBC patients (11 with DRTA and 12 without), all with normal clearance of creatinine, was assessed by dual energy radiograph absorptiometry. The diagnosis of DRTA was made if the urine pH was above 5.4 in all samples after the oral acid overload, showing tubular inability to acidify urine in the presence of test-induced systemic metabolic acidosis.
Results: Densitometric signs of osteoporosis were found in 82% of DRTA cases and in 83% of patients without DRTA (difference not significant). There were no significant differences in BMD measurement, T and Z scores of patients with and without DRTA.
Conclusions: The present study could not support a correlation between the presence of DRTA and the bone loss observed in PBC patients. 相似文献
Methods: The BMD of 23 PBC patients (11 with DRTA and 12 without), all with normal clearance of creatinine, was assessed by dual energy radiograph absorptiometry. The diagnosis of DRTA was made if the urine pH was above 5.4 in all samples after the oral acid overload, showing tubular inability to acidify urine in the presence of test-induced systemic metabolic acidosis.
Results: Densitometric signs of osteoporosis were found in 82% of DRTA cases and in 83% of patients without DRTA (difference not significant). There were no significant differences in BMD measurement, T and Z scores of patients with and without DRTA.
Conclusions: The present study could not support a correlation between the presence of DRTA and the bone loss observed in PBC patients. 相似文献
5.
From its introduction in 1847, chloroform proved to be a potent anaesthetic
agent and over the next 50 yr its use became widespread. However, in 1912
the Committee on Anaesthesia of the American Medical Association stated
that they were concerned with the occurrence of delayed chloroform
poisoning in a number of cases. This conclusion was based on case reports
and experimental animal data. However, subsequent studies and reported
series of chloroform anaesthesia in humans have suggested a lower incidence
of clinically significant liver injury. In this article we have
investigated this discrepancy by analysing the published clinical data
relating chloroform anaesthesia to liver damage.
相似文献
6.
Ali Samii Debra D Dahlen Alexander M Spence Nicole C Maronian Eric E Kraus Vanda A Lennon 《Movement disorders》2003,18(12):1556-1558
The paraneoplastic autoantibody, collapsin response-mediator protein (CRMP)-5 immunoglobulin G (IgG), is specific for neuronal cytoplasmic CRMP-5, and is usually associated with small-cell lung carcinoma or thymoma. We report on details of a movement disorder that followed anti-B-cell therapy in a patient with lymphoma, and was accompanied by CRMP-5 IgG. 相似文献
7.
W R Spence 《Healthcare executive》1989,4(5):22-23
Physicians traditionally have been considered poor entrepreneurial businessmen and investors. But the healthcare executive who takes this generalization too literally will learn some lessons the hard way. Physicians represent the largest group of successful small businessmen in the country and unlike restaurateurs, retailers or service people, physicians survive and make money over 95 percent of the time. 相似文献
8.
9.
10.
George Karpati Djordje Ajdukovic Douglas Arnold Robert B. Gledhill Ronald Guttmann Paul Holland Penelope A. Koch Eric Shoubridge Desmond Spence Michel Vanasse Gordon V. Watters Michael Abrahamowicz Catherine Duff Ronald G. Worton 《Annals of neurology》1993,34(1):8-17
One biceps muscle of 8 patients with Duchenne muscular dystrophy was injected at 55 sites with a total of 55 million viable, purified, and contamination-free normal myoblasts (myoblast transfer). The other biceps of each patient was injected with a placebo to serve as a control. The procedure was blinded to the patients, parents, and investigators. Myoblasts derived from a biopsy specimen of the fathers were cultured and purified under strict conditions and carefully screened for microbial contamination. All patients received cyclophosphamide for immunosuppression for 6 or 12 months. No serious complications were observed after myoblast transfer, indicating that the procedure is safe. The overall therapeutic efficiency of myoblast transfer was poor as judged by the results in maximal voluntary force generation, dystrophin content of the muscle, magnetic resonance imaging of the muscle, and the lack of donor-derived DNA and dystrophin messenger RNA in the injected muscle. An improved efficiency of the take of myoblasts might be achieved by using younger cells and injecting the myoblasts with a myonecrotic agent (to increase the prevalence of regeneration) and a basal laminal fenestrating agent. 相似文献